Raleigh Capital Management’s AstraZeneca AZN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q1 | – | Sell |
-778
| Closed | -$51K | – | 614 |
|
|
2024
Q4 | $51K | Sell |
778
-22
| -3% | -$1.44K | 0.02% | 315 |
|
|
2024
Q3 | $62.3K | Sell |
800
-12
| -1% | -$935 | 0.02% | 303 |
|
|
2024
Q2 | $63.3K | Buy |
812
+17
| +2% | +$1.33K | 0.03% | 280 |
|
|
2024
Q1 | $53.9K | Sell |
795
-14
| -2% | -$949 | 0.02% | 288 |
|
|
2023
Q4 | $54.5K | Hold |
809
| – | – | 0.03% | 278 |
|
|
2023
Q3 | $54.8K | Buy |
809
+29
| +4% | +$1.96K | 0.03% | 245 |
|
|
2023
Q2 | $55.8K | Hold |
780
| – | – | 0.03% | 233 |
|
|
2023
Q1 | $54.1K | Buy |
780
+10
| +1% | +$694 | 0.03% | 241 |
|
|
2022
Q4 | $52.2K | Hold |
770
| – | – | 0.03% | 238 |
|
|
2022
Q3 | $42K | Buy |
770
+6
| +0.8% | +$327 | 0.02% | 243 |
|
|
2022
Q2 | $50K | Buy |
764
+54
| +8% | +$3.53K | 0.03% | 248 |
|
|
2022
Q1 | $47K | Buy |
+710
| New | +$47K | 0.03% | 252 |
|